Shares of Lexaria Bioscience Corp. (OTCMKTS:LXRP – Get Free Report) fell 10.7% on Monday . The company traded as low as $0.21 and last traded at $0.22. 2,151,500 shares changed hands during trading, an increase of 254% from the average session volume of 608,350 shares. The stock had previously closed at $0.25.
Lexaria Bioscience Trading Down 10.7 %
The company has a quick ratio of 8.01, a current ratio of 8.52 and a debt-to-equity ratio of 0.01. The firm has a 50 day moving average price of $0.22.
About Lexaria Bioscience
Lexaria Bioscience Corp. operates in the drug delivery platform business. It develops and out-licenses its DehydraTECH technology for the delivery of bioactive compounds that promotes healthy ingestion methods, lower overall dosing, and higher effectiveness in active molecule delivery. The company has licensed DehydraTECH to various companies operating in the nicotine, pharmaceutical, nutraceutical, and vitamin industries.
See Also
- Five stocks we like better than Lexaria Bioscience
- What is Short Interest? How to Use It
- It’s Time to Buy Into the Super Micro Computer Stock Implosion
- Why Invest in High-Yield Dividend Stocks?
- Merger or Not, Albertson’s Companies is a Good Buy
- 3 REITs to Buy and Hold for the Long Term
- 3 Cheap Stocks That Shouldn’t Be So
Receive News & Ratings for Lexaria Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lexaria Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.
